In conclusion, this study demonstrated that ZIC2 may act as an oncogenic regulator in ccRCC, which is transcriptase-regulated by FOXM1 and directly regulates UBE2C expression to activate mTOR signaling pathway. This evidence concerns the gene ZIC2 and nonpapillary renal cell carcinoma.